Ex parte CHAMBON et al. - Page 12




              Appeal No.  1999-1367                                                                                       
              Application 08/453,998                                                                                      

              reasonable expectation of success.  The Evans disclosure makes no clear link between                        
              yeast and the expression control method using hormones and hormone receptor proteins.                       
              Even if one skilled in the art were to view the mention of yeast as a suggestion to try                     
              expressing a protein in yeast under the control of a hormone-responsive element and a                       
              hormone receptor, neither Evans nor Cushing (nor any of the additional references)                          
              provides a reasonable expectation of success for the method at the time the invention was                   
              made.  None of the references cited in the rejection indicate contemporary recognition in                   
              the art for cross-functionality in yeast for higher eukaryotic receptor proteins such as the                
              receptor proteins recited in appellants’ claims.  Cushing discloses an endogenous                           
              estrogen-binding protein in yeast and an endogenous estradiol-like product.  The                            
              teachings of Cushing do not lead to a reasonable expectation of success, as it was                          
              unknown if the yeast estrogen-binding protein functioned in the same manner as the                          
              mammalian estrogen receptor.  Indeed, one of ordinary skill in the art might have                           
              reasonably expected the endogenous estrogen-binding protein in yeast to compete with or                     
              interfere with the binding of estrogen to the recombinant estrogen receptor, or expected                    
              the endogenous estradiol-like compound to act as an undesired inducer.  Therefore, we                       
              see the invention as obvious to try at best, in view of the combined teachings of the                       
              references.  That is not a proper standard of obviousness.  In re O’Farrell, 853 F. 2d 894,                 
              904, 7 USPQ2d 1673, 1681(Fed. Cir. 1988).                                                                   
                                                      REVERSED                                                            

                                                           12                                                             





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007